Perry Sternberg
Förmögenhet: - $ per 2026-06-30
Förmögenhet: - $ per 2026-06-30
Perry J.
Sternberg is Chief Executive Officer & Director at Sydnexis, Inc. since 2024.
Mr. Sternberg is Lead Independent Director at Harrow, Inc. since 2022.
Mr. Sternberg is Director at Surface Ophthalmics, Inc. Formerly, Mr. Sternberg was President & Chief Executive Officer at Corium LLC (Massachusetts) from 2019 to 2024.
Mr. Sternberg was Chief Executive Officer at Corium Innovations, Inc. Mr. Sternberg was President, Chief Executive Officer & Director at Corium LLC.
Mr. Sternberg was Head-Neuroscience Business Unit at Shire Plc from 2013 to 2019.
Mr. Sternberg was Vice President & General Manager at Bausch & Lomb, Inc. Mr. Sternberg completed undergraduate studies at The Pennsylvania State University in 1990.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
HARROW, INC. -.--% | 2026-06-18 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| HARROW, INC. | Direktör/Styrelseledamot | 2022-03-31 |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Direktör/Styrelseledamot | - |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Verkställande Direktör | 2024-08-05 |
| Företag | Position | Slut |
|---|---|---|
| CORIUM INTERNATIONAL INC | Verkställande Direktör | 2024-07-01 |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Medical SpecialtiesHealth Technology Operates as a biopharmaceutical contract development and manufacturing organization that develops transdermal patches & oral thin-film systems | Verkställande Direktör | 2023-01-17 |
| SHIRE | Företagsledare/Principal | 2019-01-01 |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Företagsledare/Principal | - |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Harrow, Inc.
Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Health Technology |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Medical SpecialtiesHealth Technology Operates as a biopharmaceutical contract development and manufacturing organization that develops transdermal patches & oral thin-film systems | Health Technology |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån